SCHEMBL25016299

SCHEMBL25016299

CCOC(=O)c1cc2ccc(C(=N)NC(=O)OCC(C)C)cc2n1Cc1cc(Oc2ccsc2)cc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 5/20 0.41
▸ NOD2 Q9HC29 2/20 0.37
▸ NOD1 Q9Y239 2/20 0.37
▸ KMT2A Q03164 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ MAPT P10636 5/20 0.34
▸ TDP1 Q9NUW8 3/20 0.34
▸ TSHR P16473 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ KDM4E B2RXH2 4/20 0.34
▸ RECQL P46063 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ ELANE P08246 2/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ F2 P00734 2/20 0.33
▸ PRSS1 P07477 1/20 0.33
▸ CRHBP P24387 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25015783 0.92 F10 (0.44) F10NOD2NOD1KMT2AMEN1
SCHEMBL25015930 0.91 F10 (0.41) F10NOD2NOD1KMT2AMEN1
SCHEMBL25017612 0.88 F10 (0.41) F10NOD2NOD1KMT2AMEN1
SCHEMBL25017477 0.86 F10 (0.54) F10NOD2NOD1KMT2AMEN1
SCHEMBL21822394 0.85 F10 (0.49) F10NOD2NOD1KMT2AMEN1
SCHEMBL32665963 0.85 F10 (0.49) F10NOD2NOD1KMT2AMEN1
SCHEMBL25017211 0.84 RHEB (0.40) F10F2PRSS1
SCHEMBL25015779 0.82 F10 (0.44) F10NOD2NOD1KMT2AMEN1
SCHEMBL25015721 0.80 F10 (0.39) F10NOD2NOD1KMT2AF2
SCHEMBL25015942 0.80 RHEB (0.33) F10KMT2AF2PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE, INC. 2023-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF MMP7, MATR3, SPINT2 F10 1548/4885NOD2 3293/4885NOD1 3138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback